Literature DB >> 24525782

Systemic lupus erythematosus and lupus nephritis.

Toli Koutsokeras1, Tina Healy1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24525782     DOI: 10.1038/nrd4227

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

Review 1.  Unmet medical needs in systemic lupus erythematosus.

Authors:  Aisha Lateef; Michelle Petri
Journal:  Arthritis Res Ther       Date:  2012-12-18       Impact factor: 5.156

  1 in total
  28 in total

1.  The null polymorphism of the GSTM1/T1 gene is not associated with susceptibility to systemic lupus erythematosus: a meta-analysis.

Authors:  Lechun Lu; Dongyun Lei; Xiang Nong; Meihua Guo; Jiaqing Ma; Li He
Journal:  Mol Diagn Ther       Date:  2015-02       Impact factor: 4.074

2.  Stat1 Regulates Lupus-like Chronic Graft-versus-Host Disease Severity via Interactions with Stat3.

Authors:  Wen-Hai Shao; Ana M Gamero; Yuxuan Zhen; Monica J Lobue; Stephen O Priest; Hazem J Albandar; Philip L Cohen
Journal:  J Immunol       Date:  2015-09-21       Impact factor: 5.422

Review 3.  Peptides and peptidomimetics as immunomodulators.

Authors:  Ameya S Gokhale; Seetharama Satyanarayanajois
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

4.  Aberrant T cell subsets and cytokines expression profile in systemic lupus erythematosus.

Authors:  Haiyan Zhou; Bailong Hu; Niwen Huang; Xiangang Mo; Wei Li; Bei Zhang; Bo Wei; Mingzhu Gao; Yiming Wang; Xingde Liu; Joshua Liao
Journal:  Clin Rheumatol       Date:  2018-05-22       Impact factor: 2.980

Review 5.  The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review.

Authors:  Xin Huang; Haijing Wu; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 6.  Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.

Authors:  Shi-Yang Guan; Rui-Xue Leng; Muhammad Imran Khan; Humera Qureshi; Xiang-Pei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 7.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

Review 8.  The pathogenesis, diagnosis and treatment of lupus nephritis.

Authors:  Noa Schwartz; Beatrice Goilav; Chaim Putterman
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

Review 9.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

Review 10.  Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus.

Authors:  Tian Yu; Elena Y Enioutina; Hermine I Brunner; Alexander A Vinks; Catherine M Sherwin
Journal:  Clin Pharmacokinet       Date:  2017-02       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.